Catalyst Pharmaceuticals (CPRX) Current Deferred Revenue (2012 - 2018)
Catalyst Pharmaceuticals (CPRX) reported Current Deferred Revenue of $33408.0 for Q4 2018, up 39.14% on a YoY basis from $24011.0 in Q4 2017, and up 52.45% quarter-over-quarter from $21914.0 in Q3 2018.
Catalyst Pharmaceuticals (CPRX) Current Deferred Revenue (2012 - 2018) Analysis & Trends
Catalyst Pharmaceuticals has reported Current Deferred Revenue for 7 years, with the latest figure at $33408.0 in Q4 2018.
- For the quarter ending Q4 2018, Current Deferred Revenue rose 39.14% year-over-year to $33408.0; the trailing twelve-month figure through Dec 2018 stood at $33408.0 (up 39.14% YoY), and the FY2018 full-year result was $33408.0, up 39.14% from the prior year.
- Current Deferred Revenue for Q4 2018 stood at $33408.0, up from $21914.0 in the prior quarter.
- The five-year high for Current Deferred Revenue was $33408.0 in Q4 2018, with the low at $3254.0 in Q1 2014.
- Historically, Current Deferred Revenue has averaged $16181.7 across 5 years, with a median of $18094.0 in 2016.
- Annual changes were most pronounced in 2015 — Current Deferred Revenue soared 335.14% — and 2018, when it decreased 2.27%.
- Catalyst Pharmaceuticals' Current Deferred Revenue stood at $4158.0 in 2014, then soared by 335.14% to $18093.0 in 2015, then grew by 0.01% to $18094.0 in 2016, then surged by 32.7% to $24011.0 in 2017, then jumped by 39.14% to $33408.0 in 2018.
- The last three Current Deferred Revenue figures came in at $33408.0 (Q4 2018), $21914.0 (Q3 2018), and $27184.0 (Q2 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Catalyst Pharmaceuticals | 3.84 Bn | 3.08 Bn | 134.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 33,408.00 |
| Sep 30, 2018 | 21,914.00 |
| Jun 30, 2018 | 27,184.00 |
| Mar 31, 2018 | 25,597.00 |
| Dec 31, 2017 | 24,011.00 |
| Sep 30, 2017 | 22,424.00 |
| Jun 30, 2017 | 20,867.00 |
| Mar 31, 2017 | 19,328.00 |
| Dec 31, 2016 | 18,094.00 |
| Dec 31, 2015 | 18,093.00 |
| Sep 30, 2015 | 18,093.00 |
| Jun 30, 2015 | 5,702.00 |
| Mar 31, 2015 | 4,930.00 |
| Dec 31, 2014 | 4,158.00 |
| Sep 30, 2014 | 4,270.00 |
| Jun 30, 2014 | 3,762.00 |
| Mar 31, 2014 | 3,254.00 |
| Dec 31, 2013 | 2,746.00 |
| Sep 30, 2013 | 2,245.00 |
| Jun 30, 2013 | 1,752.00 |